Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS

Gaetano Giuffrida, MD, Concetta Conticello, MD, Daniela Nicolosi, PharmD, Valeria Calafiore, Alessandra Romano, MD PhD, Ugo Consoli, MD, Caterina Musolino, MD, Vanessa Innao, Flavia Fiorenza, MD, Cinzia Maugeri, MD, Giuseppe Longo, MD, Maria Rocca Cingari, MD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4868.

https://doi.org/10.1182/blood-2019-129944

Published: 2019

Journal Articles

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness Overcoming Bortezomib Resistance in Myeloma Plasma Cells

Cesarina Giallongo, PhD, Daniele Tibullo, PhD, Giuseppina Camiolo, Fabrizio Puglisi, Daniela Cambria, Alessandro Barbato, Nunziatina Laura Parrinello, PhD, Alessandra Romano, MD PhD, Concetta Conticello, MD, Angela Amorini, PhD, Giovanni Li Volti, MD PhD, Giuseppe Lazzarino, Giuseppe A. Palumbo, MD PhD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 3073.

https://doi.org/10.1182/blood-2019-129812

Published: 2019

Journal Articles

Ixazomib Modulates Bone Remodeling and Actives Sonic Hedgehog Pathways

Daniele Tibullo, PhD, Anna Longo, PhD, Alessandra Romano, MD PhD, Alessandro Barbato, Cesarina Giallongo, PhD, Michelino Di Rosa, PhD, Carmelina Daniela Anfuso, Gabriella Lupo, Concetta Conticello, MD, Nunzio Vicario, PhD, Rosario Gulino, PhD, Rosalba Parenti, PhD, Giuseppe A. Palumbo, MD PhD, Giovanni Li Volti, MD PhD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4345.

https://doi.org/10.1182/blood-2019-129927

Published: 2019

Journal Articles

VTE Incidence in RRMM Patients Treated with NOVEL Agents: A Monocentric Real Life Experience

Gaetano Giuffrida, MD, Concetta Conticello, MD, Valeria Calafiore, Enrica Antonia Martino, MD, Silvia Giamporcaro, MD, Alessandra Romano, MD PhD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4972.

https://doi.org/10.1182/blood-2019-131015

Published: 2019

Journal Articles

Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Alessandra Pompa, Concetta Conticello, MD, Diana Giannarelli, PhD, Loredana Pettine, MD, Laura Paris, MD, Lucia Tognazzi, Magda Marcatti, MD, Elisabetta Antonioli, MD, Francesca Fioritoni, MD, Angela Bonalumi, MD, Silvia Mangiacavalli, Paola Bertazzoni, Iolanda Donatella Vincelli, MD, Daniele Derudas, MD, Agostina Siniscalchi, Sara Pezzatti, MD, Renato Zambello, Annalisa Citro, MD, Angelo Belotti, Alessandra Lombardo, MD, Federico Vozella, MD, Adelina Sementa, MD, Ugo Consoli, MD, Alfredo Molteni, MD, Niccolò Frungillo, MD, Massimo Gentile, MD, Gabriele Buda, MD PhD, Sara Aquino, Salvatore Palmieri, Velia Bongarzoni, MD, Alessandro Inzoli, MD, Valeria Ferla, MD, Francesca Gaia Rossi, MD, Valerio Leotta, MD, Alessandra Romano, MD PhD, Federica Elia, MD, Vittorio Del Fabro, MD, Guido Montanaro, MD, Francesca Cavallaro, MD, Monica Galli, Luca Baldini, MD PhD

Blood (2019) 134 (Supplement_1): 5555.

https://doi.org/10.1182/blood-2019-125098

Published: 2019

Journal Articles

Early Salvage Treatment with Second-Generation Novel Agents at Biochemical Relapse Prolongs Overall Survival: A Real-World Single Center Experience

Uros Markovic, MD, Valerio Leotta, MD, Alessandra Romano, MD PhD, Vittorio Del Fabro, MD, Giuseppe Sapienza, MD, Enrica Antonia Martino, MD, Marina Parisi, MD, Valeria Calafiore, Francesco Di Raimondo, MD, Concetta Conticello, MD

Blood (2019) 134 (Supplement_1): 5530.

https://doi.org/10.1182/blood-2019-130415

Published: 2019

Journal Articles

Long Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Real Life Experience

Concetta Conticello, Marina Parisi, MD, Salvatore Leotta, Nunziatina Laura Parrinello, Enrica Martino, Valeria Calafiore, Maria Cristina Pirosa, Urosh Markovic, Alessandra Romano, MD PhD, Francesco Di Raimondo, MD

Blood (2018) 132 (Supplement 1): 5669.

https://doi.org/10.1182/blood-2018-99-120105

Published: 2018

Journal Articles

Role of TLR4 in the Activation of a Pro-Tumor Phenotype of Mesenchymal Stromal Cells in Mutiple Myeloma

Cesarina Giallongo, PhD, Daniele Tibullo, Nunziatina Laura Parrinello, Giuseppina Camiolo, Piera La Cava, Alessandra Romano, MD PhD, Fabrizio Puglisi, Giuseppe Sapienza, Concetta Conticello, Giuseppe A. Palumbo, MD, Francesco Di Raimondo, MD

Blood (2018) 132 (Supplement 1): 1892.

https://doi.org/10.1182/blood-2018-99-118320

Published: 2018

Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma

Blood (2016) 128 (22): 4161.

https://doi.org/10.1182/blood.V128.22.4161.4161

Published: 2016

Journal Articles

Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity

Cesarina Giallongo, Daniele Tibullo, PhD, Nunziatina Laura Parrinello, Piera La Cava, Giuseppina Camiolo, Nunzia Caporarello, Carmelina Daniela Anfuso, Fabrizio Puglisi, Concetta Conticello, MD, Maria Violetta Brundo, Alessandra Romano, MD PhD, Francesco Di Raimondo, MD

Blood (2016) 128 (22): 4458.

https://doi.org/10.1182/blood.V128.22.4458.4458

Published: 2016

Journal Articles

Immune Suppression By High-Density Neutrophils Predicts Short Progression-Free Survival in Multiple Myeloma

Alessandra Romano, MD PhD, Jose Manteiga, PhD, Vittorio Simeon, PhD, Nunziatina L Parrinello, Cesarina Giallongo, Piera La Cava, Concetta Conticello, MD, Daniele Tibullo, PhD, Francesca Fontana, Fabio Ciceri, MD, Floriana Cremasco, Monica Fabbri, Pellegrino Musto, Simone Cenci, MD, Francesco Di Raimondo, MD

Blood (2016) 128 (22): 4459.

https://doi.org/10.1182/blood.V128.22.4459.4459

Published: 2016

Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Blood (2016) 128 (22): 3007.

https://doi.org/10.1182/blood.V128.22.3007.3007

Published: 2016

Journal Articles

Arginase 1 Is a Marker of Myeloid-Mediated Immunosuppression with Prognostic Meaning in Classic Hodgkin Lymphoma

Alessandra Romano, MD PhD, Nunziatina L Parrinello, Daniele Tibullo, PhD, Calogero Vetro, MD, Cesarina Giallongo, Piera La Cava, Annalisa Chiarenza, Loredana Villari, Claudio Tripodo, MD, Giovanna Motta, Laura Caruso, Andrea Gallamini, MD, Stefano A Pileri, Francesco Di Raimondo, MD

Blood (2016) 128 (22): 1770.

https://doi.org/10.1182/blood.V128.22.1770.1770

Published: 2016

Journal Articles

Contribution of High-Density Neutrophils to Multiple Myeloma Microenvironment Dysregulation

Alessandra Romano, MD PhD, Cesarina Giallongo, Nunziatina L Parrinello, Daniele Tibullo, PhD, Fabrizio Puglisi, Giusy Camiolo, Piera La Cava, Marina Parisi, maria Letizia Consoli, Concetta Conticello, MD, Francesco Di Raimondo, MD, Vanella Luca

Blood (2016) 128 (22): 5643.

https://doi.org/10.1182/blood.V128.22.5643.5643

Published: 2016

Journal Articles

The Combined Evaluation of Neutrophil, T-Lymphocyte and Monocyte Counts Provides New Prognostic Information in CLL Patients

Annalisa Chiarenza, Nunziatina Laura Parrinello, Anna Maria Triolo, Giuseppina Rizzo, Alessandra Romano, MD PhD, Cinzia Maugeri, Laura Anastasia Caruso, Giovanna Motta, Amalia Figuera, Angelo Curto Pelle, Valerio Leotta, Mary Ann Di Giorgio, Piera La Cava, Cesarina Giallongo, Daniele Tibullo, PhD, Francesco Di Raimondo, MD

Blood (2016) 128 (22): 5565.

https://doi.org/10.1182/blood.V128.22.5565.5565

Published: 2016

Journal Articles

Sucrosomial Technology Is Able to Promote Ferric Iron Absorption: Pre-Clinical and Clinical Evidences

Elisa Brilli, PhD, Alessandra Romano, MD PhD, Angela Fabiano, PhD, Ylenia Zambito, PhD, Francesco Di Raimondo, MD, Germano Tarantino, MD

Blood (2016) 128 (22): 3618.

https://doi.org/10.1182/blood.V128.22.3618.3618

Published: 2016

Journal Articles

Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib

Cesarina Giallongo, Nunziatina L Parrinello, Daniele Tibullo, PhD, Piera La Cava, Alessandra Romano, MD PhD, Annalisa Chiarenza, Fabio Stagno, MD PhD, Paolo Vigneri, MDPhD, Giuseppe A Palumbo, Francesco Di Raimondo, MDPhD, Claudia Bellofiore

Blood (2015) 126 (23): 2767.

https://doi.org/10.1182/blood.V126.23.2767.2767

Published: 2015

Journal Articles

Plasmocytosis and Immunoparesis but Not Neutrophil to Lymphocyte Ratio Can Predict Time to Treatment in Smoldering Myeloma

Alessandra Romano, MD PhD, Marzia L Consoli, Marina Parisi, Maide Cavalli, Nunziatina L Parrinello, Concetta Conticello, MD, Francesco Di Raimondo, MDPhD

Blood (2015) 126 (23): 5358.

https://doi.org/10.1182/blood.V126.23.5358.5358

Published: 2015

Journal Articles

Mesenchymal STEM CELLS Favor Tumor Growth By Generating Granulocyte-like Myeloid Derived Suppressor CELLS in CML Patients

Cesarina Giallongo, Nunziatina L Parrinello, Daniele Tibullo, PhD, Claudia Bellofiore, Piera La Cava, Alessandra Romano, MD PhD, Annalisa Chiarenza, Fabio Stagno, MD PhD, Paolo Vigneri, MDPhD, Giuseppe A. Palumbo, MD, Francesco Di Raimondo, MDPhD

Blood (2015) 126 (23): 4018.

https://doi.org/10.1182/blood.V126.23.4018.4018

Published: 2015

Journal Articles

Myeloid Dysfunction in Sickle Cell Disease

Alessandra Romano, MD PhD, Nunziatina Laura Parrinello, PhD, Concetta Conticello, MD, Rossellina Rosso, MD, Perrotta Caterina, Grazia Colletta, MD, Benedetta Ximenes, Piera La Cava, Carmela RITA Meli, Francesco Di Raimondo, MD

Blood (2014) 124 (21): 4908.

https://doi.org/10.1182/blood.V124.21.4908.4908

Published: 2014

NARROW

Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness Overcoming Bortezomib Resistance in Myeloma Plasma Cells

Ixazomib Modulates Bone Remodeling and Actives Sonic Hedgehog Pathways

VTE Incidence in RRMM Patients Treated with NOVEL Agents: A Monocentric Real Life Experience

Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Early Salvage Treatment with Second-Generation Novel Agents at Biochemical Relapse Prolongs Overall Survival: A Real-World Single Center Experience

Long Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Real Life Experience

Role of TLR4 in the Activation of a Pro-Tumor Phenotype of Mesenchymal Stromal Cells in Mutiple Myeloma

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma

Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity

Immune Suppression By High-Density Neutrophils Predicts Short Progression-Free Survival in Multiple Myeloma

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Arginase 1 Is a Marker of Myeloid-Mediated Immunosuppression with Prognostic Meaning in Classic Hodgkin Lymphoma

Contribution of High-Density Neutrophils to Multiple Myeloma Microenvironment Dysregulation

The Combined Evaluation of Neutrophil, T-Lymphocyte and Monocyte Counts Provides New Prognostic Information in CLL Patients

Sucrosomial Technology Is Able to Promote Ferric Iron Absorption: Pre-Clinical and Clinical Evidences

Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib

Plasmocytosis and Immunoparesis but Not Neutrophil to Lymphocyte Ratio Can Predict Time to Treatment in Smoldering Myeloma

Mesenchymal STEM CELLS Favor Tumor Growth By Generating Granulocyte-like Myeloid Derived Suppressor CELLS in CML Patients

Myeloid Dysfunction in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only